Product Information
FLUCONAZOLE 40 MG/ML SUSP is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.5468 per ML under NDC 59762503001. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 23, 1993. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762503001
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLUCONAZOLEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020090FDA Approved
12/23/1993
TE Code
AB
On Market Since
12/23/1993
Pharmacological Classes
Price Statistics
The NADAC for FLUCONAZOLE 40 MG/ML SUSP has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 5.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5468 per ML |
|---|---|
| All-time high | $0.8489 (Oct 12, 2016) |
| All-time low | $0.4151 (Oct 18, 2023) |
| 52-week high | $0.5843 |
| 52-week low | $0.5007 |
| Median price | $0.6381 |
| Average price | $0.6380 |
| Largest weekly change | +33.2% (Sep 21, 2022) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the fluconazole market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fluconazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUCONAZOLE 40 MG/ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for FLUCONAZOLE 40 MG/ML SUSP, manufactured by Mylan Pharmaceuticals Inc., is $0.5468 per ML (NDC 59762503001), effective Sep 30, 2026.
How has the price of FLUCONAZOLE 40 MG/ML SUSP changed over time?
Over the history we have for it, the NADAC for FLUCONAZOLE 40 MG/ML SUSP has declined 5.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FLUCONAZOLE 40 MG/ML SUSP?
Since Nov 28, 2013, the NADAC for FLUCONAZOLE 40 MG/ML SUSP has ranged from a low of $0.4151 (Oct 18, 2023) to a high of $0.8489 (Oct 12, 2016), with a median of $0.6381 per ML.
Are there cheaper alternatives to FLUCONAZOLE 40 MG/ML SUSP?
No other NADAC-published product currently shares the active ingredient and strength of FLUCONAZOLE 40 MG/ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FLUCONAZOLE 40 MG/ML SUSP?
FLUCONAZOLE 40 MG/ML SUSP (NDC 59762503001) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.